Glaukos Corp (GKOS)
112.72
+2.02
(+1.82%)
USD |
NYSE |
May 31, 16:00
112.89
+0.17
(+0.15%)
Pre-Market: 20:00
Glaukos Cash from Operations (Annual): -57.76M for Dec. 31, 2023
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -57.76M |
| December 31, 2022 | -33.08M |
| December 31, 2021 | 24.71M |
| December 31, 2020 | -22.99M |
| December 31, 2019 | -0.369M |
| December 31, 2018 | 18.86M |
| Date | Value |
|---|---|
| December 31, 2017 | 26.09M |
| December 31, 2016 | 12.31M |
| December 31, 2015 | -2.188M |
| December 31, 2014 | -7.107M |
| December 31, 2013 | -13.30M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
-57.76M
Minimum
2023
24.71M
Maximum
2021
-17.90M
Average
-22.99M
Median
2020
Cash from Operations (Annual) Benchmarks
| Boston Scientific Corp | 2.503B |
| Accuray Inc | 15.54M |
| Alphatec Holdings Inc | -78.48M |
| Asensus Surgical Inc | -63.63M |
| iRhythm Technologies Inc | -50.10M |